alexion fourth quarter beat expect
guidanc disappoint volum outlook
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data feb
rate updat feb
currenc amount express
methodolog valu compani
earn total revenu billion
last year adjust net incom million
last year beat analyst
expect beat larg driven strong
launch soliri gener myasthenia gravi gmg
expect main driver growth
soliri addit potenti mid-year launch
approv manag guidanc top-lin growth
lower expect seemingli soliri
volum oper spend guidanc percentag
total revenu much lower anticip
review model firm full-year file
releas expect chang fair valu
estim per share
fourth-quart growth driven volum growth
compar last year slightli off-set price foreign
exchang effect fourth quarter price headwind
higher expect due rebat
turkey although compani disclos mani
detail believ could indic alexion find
difficulti secur reimburs smaller intern
market forc price
order formal
price guidanc headwind slightli
better previous model indic
compani belief overal price stabil
sustain price strategi key goal alexion
evidenc fact recent approv ultomiri
next-gener version soliri offer patient
much conveni dose schedul price
discount soliri firm price strategi help
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
special develop market drug
life-threaten medic condit blockbust product soliri
approv therapi paroxysm nocturn hemoglobinuria
atyp hemolyt urem syndrom two ultra-rar blood disord
recent approv gener myasthenia gravi strensiq kanuma
target ultra-rar metabol diseas alexion pipelin target area
high unmet need complement-medi disord
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
secur rapid reimburs aid compani lofti
convers goal convert pnh patient
ultomiri next two year aggress
convers effort dampen growth expect
near term view necessari strategi ward
signific declin soliri biosimilar begin enter
market potenti earli europ
smaller
estim manag revenu guidanc
indic overal volum growth mid-teen slightli
lower expect partial due announc
million revenu headwind soliri switch third-
addit soliri volum cannib
late-stag ultomiri trial gmg nmosd atyp
competitor reach late-stag trial
neg impact soliri volum potenti growth
continu believ soliri set high bar
efficaci safeti despit competitor progress
look forward expect alexion add modestli
recent fortifi pipelin last month
compani ad three clinical-stag candid wilson
therapeut wilson diseas
million acquisit syntimmun
rare igg-medi diseas million
acquisit caelum bioscienc light
option acquir candid
contribut significantli valuat yet see
addit import step manag fill
gap pipelin shift concentr away
soliri ultomiri addit compani test
ultomiri next-gener subcutan version
sever indic expect soliri approv
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
